Deferred Revenue (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Aug. 31, 2016 |
Nov. 30, 2015 |
May 31, 2015 |
Dec. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Deferred Revenue Arrangement [Line Items] | ||||||
Deferred revenue | $ 1,250,000 | $ 4,500,000 | ||||
Grants receivable | 1,000,000 | |||||
Revenue | 1,911,424 | $ 648,382 | ||||
Cystic Fibrosis Foundation Therapeutics Inc [Member] | ||||||
Deferred Revenue Arrangement [Line Items] | ||||||
Deferred revenue | 500,000 | |||||
Amount received upon execution of award agreement | $ 1,000,000 | $ 1,250,000 | $ 1,250,000 | $ 1,250,000 | $ 500,000 |
X | ||||||||||
- Definition Deferred Revenue Gross No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of consideration recognized during the period for the milestone or milestones. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|